n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with phenylalanine in 1 studies
Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (phenylalanine) | Trials (phenylalanine) | Recent Studies (post-2010) (phenylalanine) |
---|---|---|---|---|---|
79 | 1 | 16 | 23,695 | 721 | 4,367 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moreira, R; Santos, MM | 1 |
1 review(s) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and phenylalanine
Article | Year |
---|---|
Michael acceptors as cysteine protease inhibitors.
Topics: Animals; Cysteine Proteinase Inhibitors; Drug Design; Humans; Isoxazoles; Leucine; Molecular Structure; Oxazoles; Peptides; Phenylalanine; Pyrrolidines; Pyrrolidinones; Structure-Activity Relationship; Sulfones; Valine | 2007 |